North America Aquaculture Vaccines Market Size & Outlook
North America aquaculture vaccines market, 2018-2030 (US$M)
Related Markets
North America aquaculture vaccines market highlights
- The North America aquaculture vaccines market generated a revenue of USD 94.9 million in 2023.
- The market is expected to grow at a CAGR of 8.3% from 2024 to 2030.
- In terms of segment, inactivated (killed) was the largest revenue generating vaccine type in 2023.
- Other Vaccines is the most lucrative vaccine type segment registering the fastest growth during the forecast period.
- Country-wise, U.S. is expected to register the highest CAGR from 2024 to 2030.
North America data book summary
| Market revenue in 2023 | USD 94.9 million |
| Market revenue in 2030 | USD 165.7 million |
| Growth rate | 8.3% (CAGR from 2023 to 2030) |
| Largest segment | Inactivated (killed) |
| Fastest growing segment | Other Vaccines |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Modified/ Attenuated Live, Inactivated (Killed), Other Vaccines |
| Key market players worldwide | Zoetis, Phibro Animal Health Corp Class A, Elanco Animal Health Inc, Merck & Co Inc, Choong Ang Vaccine Laboratories (CAVAC), Kyoto Biken Laboratories, Nissenken, KBNP, Vaxxinova, HIPRA |
Other key industry trends
- In terms of revenue, North America region accounted for 23.9% of the global aquaculture vaccines market in 2023.
- Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 180.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Aquaculture Vaccines Market Scope
Aquaculture Vaccines Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America aquaculture vaccines market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to aquaculture vaccines market will help companies and investors design strategic landscapes.
Inactivated (killed) was the largest segment with a revenue share of 34.56% in 2023. Horizon Databook has segmented the North America aquaculture vaccines market based on modified/ attenuated live, inactivated (killed), other vaccines covering the revenue growth of each sub-segment from 2018 to 2030.
As per a report by the World Ocean Review, about 600 aquatic species are grown commercially across the globe via aquaculture. Vaccination offers a safer alternative for protecting fish health over antibiotics and other measures used to curb a disease outbreak.
For instance, Salmon fish can be vaccinated during its first year of life in the fresh-water phase, as it is most likely to encounter pathogens during the sea-water phase of the farming cycle. North America held a significant share of the global aquaculture vaccines market in 2020.
This can be attributed to factors such as the demand for sustainable and safe aquaculture production, advancements in the industry, and supportive government initiatives. Veterinary biologics for aquaculture are regulated in the U.S. by the Department of Agriculture (USDA) in tandem with other regulatory bodies at national and local levels.
Reasons to subscribe to North America aquaculture vaccines market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America aquaculture vaccines market databook
-
Our clientele includes a mix of aquaculture vaccines market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America aquaculture vaccines market , including forecasts for subscribers. This continent databook contains high-level insights into North America aquaculture vaccines market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America aquaculture vaccines market size, by country, 2018-2030 (US$M)
North America Aquaculture Vaccines Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
